Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Nov 1, 2013

5229_dirs_2013-11-01_43093a2c-4868-4e45-a538-453935e8e3ea.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0143S

AstraZeneca PLC

01 November 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 31 October 2013, the interest of Mr Pascal Soriot, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.

The change in interest relates to the previously announced award of restricted shares made in October 2012 in connection with Mr Soriot's appointment as Chief Executive Officer. The award vests in three tranches over three years.

After sufficient shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Soriot has become beneficially entitled to and has received 23,981 shares into a personal brokerage account in respect of the first tranche of the award.

For tax purposes, the fair market value of the shares at vest was 3330 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.

Following the vesting, Mr Soriot has a total interest in 411,917 AstraZeneca shares.

A C N Kemp

Company Secretary

1 November 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUAOOROOAARAA